SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel $INTC is trending as chatter swirls around a potential investment from Apple $AAPL as part of Intel's turnaround efforts, fueled by a recent Bloomberg report. Community members are speculating about the implications of Apple taking a stake and potential collaborations, while some express skepticism, recalling past struggles. The news arrives amid broader discussions of government support for US chip manufacturing and Intel's role in the AI landscape.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to a surge in investor interest, fueled by a recent Air Force contract and non-dilutive funding, which validates the company's quantum computing roadmap. The community is actively discussing the stock's potential, comparing it to other high-growth tech stocks and debating whether it's overvalued. Some traders are pointing to a potential short squeeze, while others highlight the long-term potential of quantum computing and the company's partnerships.

Lithium Americas Corp. engages in the development of the Thacker Pass project. It is focused on advancing Thacker Pass to production it is located in northern Nevada. The company was founded on January 23, 2023 and is headquartered in Vancouver, Canada.

Lithium Americas Corp (NewCo)

Lithium Americas Corp

Lithium Americas ($LAC) is trending due to reports of the Trump administration potentially taking an equity stake in the company linked to a $2.26 billion Energy Department loan, sparking significant community discussion around potential government backing and the future of lithium supply. The news has triggered a surge in the stock price as investors speculate on the implications for the company's Thacker Pass project and the broader lithium sector, with some comparing it to previous government investments in critical industries. Discussions also include potential dilution and off-take agreements.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure ($QURE) is trending following positive Phase I/II data for its Huntington's disease gene therapy, with analysts raising price targets and the community discussing its potential for accelerated FDA approval. Bullish sentiment is fueled by the statistically significant slowing of disease progression, while some traders are wary of a potential offering or pullback. The stock's high short interest is adding to the volatility as traders debate whether to short the stock or ride the momentum.

TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

TNF Pharmaceuticals Inc.

TNF Pharmaceuticals (TNFA) is trending as traders discuss its recent strategic shift towards quantum computing and a name change to Q/C Technologies, sparking both excitement and skepticism. Bullish sentiment centers on the potential of their exclusive rights to light-speed laser processing for cryptocurrency applications, while bears cite concerns about dilution and the company's history. The community is actively debating whether this pivot justifies the stock's increased volatility and potential for a short squeeze.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

ALAB is trending due to a significant sell-off, with community members citing potential Intel/Nvidia competition and overvaluation concerns as possible catalysts; some suspect market manipulation. Despite strong YTD growth fueled by PCIe demand and a recent positive earnings report, investors are debating its sustainability amid competition from major players like AVGO and MRVL. Discussions include whether the drop is a buying opportunity or a sign of further declines.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending amid speculation about a potential buyout or partnership, especially with other companies in the weight loss space being acquired. Community members are actively discussing potential suitors and the value of Viking's pipeline, citing positive trial data and a manageable tolerability profile. Some traders are eyeing technical indicators, while others are focused on upcoming presentations and potential catalysts.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending amid debates about its valuation and future prospects, with discussions focusing on its lack of current revenue and potential for an offering. Community sentiment is divided, with some highlighting insider selling and regulatory hurdles, while others point to the company's potential role in powering AI data centers. The stock's significant gains over the past month have also spurred conversations around pullbacks and potential buying opportunities within the nuclear sector.

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Immuneering Corp - Ordinary Shares Class A

IMRX is trending following news of a clinical supply agreement with Eli Lilly to evaluate atebimetinib in combination with olomorasib for non-small cell lung cancer, leading to a significant surge in the stock price. The community is discussing the potential of this collaboration and its implications for Immuneering's pipeline strategy, while analysts adjust their ratings with some setting buy ratings and price targets. Some investors are speculating whether Lilly may eventually acquire Immuneering.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as the community discusses its recent price movement and potential breakout above the $15-$16 resistance level, with some pointing to a shift in market sentiment. The groundbreaking of the Georgia plant is also generating buzz, although some express concerns about cash burn and production timelines. Overall, the conversation is focused on whether Rivian can maintain its upward momentum and capitalize on upcoming catalysts like the R2 launch.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of ASP Isotopes (ASPI) closed 6.1% higher at $9.36 on Friday.Last week, the company struck a four-year supply agreement with Isotopia Molecular Imaging to deliver enriched Gadolinium-160 (Gd-160), a key ingredient in producing Terbium-161 (Tb-161), a promising isotope for targeted radiotherapeutics.ASP will supply the isotope using its proprietary Quantum Enrichment technology from 2026, and&nbsp;the deal is expected to generate at least $1 million per year.The agreement is designed to help overcome persistent supply shortages of Gd-160, enabling Isotopia to advance its Tb-161-based treatments for cancers like prostate and neuroendocrine tumors.“By supplying Gd-160, we are eliminating a major bottleneck in the development of Tb-161 therapies. Our investment in enrichment technology positions us to support the radiopharmaceutical industry’s growing demand for stable isotopes,” said Paul Mann, CEO of ASP Isotopes.“This partnership accelerates the path to clinical adoption of Tb-161, which could redefine cancer treatment paradigms.”Last month, ASP signed a deal to supply enriched uranium to TerraPower, the nuclear energy company backed by Bill Gates.&nbsp;As part of the agreement, TerraPower will provide ASP with a multiple-advance term loan to help fund a planned uranium enrichment facility at Pelindaba, South Africa.Retail sentiment on Stocktwits remained ‘bullish’ ahead of Monday’s trading session.<figure class="image"><img style="aspect-ratio:969/96;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_09_122253_png_3a77496e48.webp" alt="Screenshot 2025-06-09 122253.png" width="969" height="96"><figcaption>ASPI's Sentiment Meter and Message Volume as of 3:17 a.m ET on June 9, 2025 | Source: Stocktwits&nbsp;</figcaption></figure>One user believes the stock should reach at least $20 before considering selling.<stembedurl>https://stocktwits.com/trent1229/message/617231598</stembedurl><a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes stock</a> has gained over 100% year-to-date.

DocuSign expects the new agreement to expedite the advancement of its IAM platform and deliver more intelligent and efficient solutions to its customers. 

ASP Isotopes Stock Jumps On Isotopia And TerraPower Tie-Ups: Retail Stays Bullish

The Isotopia agreement aims to deliver enriched Gadolinium-160 (Gd-160) to aid targeted radiotherapeutics

Equity

ASP Isotopes (ASPI) stock jumped in extended trading on Monday after the company signed an agreement to supply enriched uranium to Bill Gates-backed nuclear energy firm TerraPower.Under the agreement terms, Terrpower would provide ASP with a multiple-advance term loan to partially finance a proposed new uranium enrichment facility at Pelindaba, South Africa.The facility would be capable of producing high-assay low-enriched uranium (HALEU) with an annual output of approximately 15 metric tons.The company also agreed to supply HALEU for the first fuel core for TerraPower’s Natrium Plant in Wyoming. ASP expects to provide 150 metric tons of HALEU from 2028 through the end of 2037.The South Africa facility is expected to begin operations in 2027 upon receipt of all required permits and licenses.Monday’s agreement finalized a term sheet agreement between the two companies, which was struck last year.“Nuclear fuel has one of the most severely compromised supply chains of any material in the world. The world is in urgent need of additional suppliers,” ASP CEO Paul Mann said.HALEU is enriched between 5% and 20% and is the key to many advanced, smaller reactors with more power per unit of volume.There is a broad bipartisan support for nuclear power, which the U.S. lawmakers believe could be the answer to the rapid rise in power demand. However, currently, Russia is the only viable HALEU supplier of scale.The companies said they would explore opportunities to produce HALEU within the U.S.Retail sentiment on Stocktwits was in the ‘extremely bullish’ (81/100) territory, while retail chatter was ‘extremely high.’<figure class="image"><img style="aspect-ratio:878/102;" src="https://news.stocktwits-cdn.com/ASPI_May_20_JPG_2e0ea8a23b.webp" alt="ASPI’s Sentiment Meter and Message Volume as of 02:47 a.m. ET on May 20, 2025 | Source: Stocktwits" width="878" height="102"><figcaption>ASPI’s Sentiment Meter and Message Volume as of 02:47 a.m. ET on May 20, 2025 | Source: Stocktwits</figcaption></figure>“This feels like where we were before Fuzzy Panda. This time, though, even though its prospects and potential are the same as then, the company is in a stronger position,” one retail trader said.<stembedurl>https://stocktwits.com/wilmeriken/message/615185094</stembedurl>The stock declined in November after short seller Fuzzy Panda <a href="https://stocktwits.com/news-articles/markets/equity/aspi-stock-slides-after-fuzzy-panda-short-call/cJIWDFNRWc">accused the company</a> of misleading investors. ASP had denied the allegations.<a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes stock</a> has gained 60% year to date (YTD).Also See: <a href="https://stocktwits.com/news-articles/markets/equity/citi-downgrades-patterson-uti-helmerich-and-payne-on-oil-price-risk/ch0dF7jRb8M">Citi Downgrades Patterson-UTI, Helmerich &amp; Payne On Oil Price Risk — Retail Surprised By ‘Brutal’ Selloff</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

ASP Isotopes Rises On Deal With Bill Gates-Backed TerraPower — Retail Says Company Can Finally Move Beyond Short-Seller Report

Under the agreement terms, Terrpower would provide ASP with a multiple-advance term loan to partially finance a proposed new uranium enrichment in South Africa.

ASP Isotopes Rises On Deal With Bill Gates-Backed TerraPower

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ASP Isotopes Inc. (NASDAQ: ASPI)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ASP Isotopes Inc. (NASDAQ: ASPI) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...

4 Top-Rated Nuclear Energy Stocks to Buy in February 2025

These nuclear energy stocks all are loved by analysts and have significant upside potential over the next 12 months.

ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit with the Schall Law Firm

ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit with the Schall Law Firm ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit with the...

Final Deadline for the ASP Isotopes Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ASP

Final Deadline for the ASP Isotopes Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ASP Final Deadline for the ASP Isotopes Inc. Securities Lawsuit - Contact the DJS Law...

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ASP Isotopes

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ASP Isotopes Inc. (ASP Isotopes or the Company) (NASDAQ: ASPI) and reminds investors of the...

Investors in ASP Isotopes Inc. Should Contact The Gross Law Firm Before February 3, 2025 to Discuss Your Rights - ASPI

Investors in ASP Isotopes Inc. Should Contact The Gross Law Firm Before February 3, 2025 to Discuss Your Rights - ASPI Investors in ASP Isotopes Inc. Should Contact The Gross Law Firm Before February...

ASPI Deadline: Rosen Law Firm Urges ASP Isotopes Inc. (NASDAQ: ASPI) Stockholders with Losses to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers and acquirers of ASP Isotopes Inc. (NASDAQ: ASPI) securities...

ASPI Deadline: ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit

ASPI Deadline: ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit ASPI Deadline: ASPI Investors Have Opportunity to Lead ASP Isotopes Inc. Securities Fraud Lawsuit PR...

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

Will Costco Wholesale ($COST) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

Stocktwits

Costco Wholesale Corp

) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

Current Price	$11.12
Prev Close	$11.44
Open	$11.56
Dividend Yield	0.00%
50-Day Moving Average	$9.46
Beta	2.33
Avg. Volume	4.51M
PE Ratio	-8.18

52-Week High	$11.86
52-Week Low	$2.61
Market Capitalization	$1.05B
EPS (Annual)	-$0.6307
Price to Book	38.04
Revenue Per Employee	$30,472.25
Enterprise Value/EBITDA	N/A

ASPI
ASP Isotopes Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ASPI News

ASPI ASP Isotopes Inc